Internal funding opportunities
PMU Research & Innovation Fund (PMU-RIF)

After funding approval

• Notification of names and addresses of the workplace and supervisors for contract preparation (via email to forschung.service[at]pmu.ac.at).
• Provide a cost center for each applicant (a project-specific cost center). If the project is being managed through PMU, you can apply for the cost center here; for SALK employees, please contact Ms. Zoll (i.zoll[at]salk.at) (Please send the cost center details via email to  forschung.service[at]pmu.ac.at).
• Provide the project start date.
• Afterward, the first tranche of 40% of the funding amount will be disbursed.

Six months after project start

• Submission of a progress report (submitted by the PI) every 6 months. This should include information on expenses incurred so far and the current status of the project, organized by work packages.
• half a DIN A4 page is sufficient.
• submit via email to forschung.service[at]pmu.ac.at.

18 months after project start

• Submission of an interim report (submitted by the PI), which should include:

1. Information on expenses incurred so far (extract from the accounting system)
2. Project status (half a DIN A4 page is sufficient)
3. Submit via email to  forschung.service[at]pmu.ac.at

• The interim report will then be reviewed and approved by a member of the RIF allocation board.
• After approval, the second tranche of 40% of the funding will be disbursed.

Six weeks after project completion

• Submission of a final report (submitted by the PI), which should include:

1. Comparison between the project proposal and project completion (description of the individual work packages, whether everything went according to plan, if objectives had to be adjusted, and key findings).
2. Which publications or similar outputs have been or will be produced?
3. Financial summary: extract from the accounting system & invoices as PDFs.
4. Submit via email to forschung.service[at]pmu.ac.at.

• The final report will be reviewed and approved by a member of the RIF allocation board.
• After approval, the third and final tranche of 20% of the funding will be disbursed.

If desired, reports can be generated using our general template.

After funding approval

• Notification of names and addresses of the workplace and supervisors for contract preparation.
• Provide a cost center (project-specific). If there are multiple applicants, please provide one cost center per legal entity. If the project is being managed through PMU, you can apply for the cost center here; SALK employees should contact Ms. Zoll (i.zoll[at]salk.at).
• Provide the project start date and the expected end date.
• Afterward, the first tranche of 90% of the funding amount will be disbursed.

6 months after project start

• Submission of an interim report, which must include:

1. The current status of the project (half a DIN A4 page is sufficient).
2. Information on expenses incurred so far—extract from the accounting system.

• The interim report will be reviewed and approved by a member of the RIF allocation board.

After project completion:

• Submission of a final report, which must include:

1. Comparison between the project proposal and project completion (description of individual work packages, whether everything went according to plan, if objectives had to be adjusted, and the key findings).
2. Which publications or similar outputs have resulted or are expected?
3. Financial summary: extract from the accounting system & invoices as PDFs.

• The final report will be reviewed and approved by a member of the RIF allocation board.
• After approval, the second tranche of 10% of the funding will be disbursed.

If desired, reports can be generated using our general template.

After funding approval

• Notification of the names and addresses of the workplace and supervisors for contract preparation.
• Provide a cost center (project-specific). If the project is being managed through PMU, you can apply for the cost center here; SALK employees should contact Ms. Zoll (i.zoll[at]salk.at).
• Provide the start date and the expected end date of the project.
• Provide the expected completion date of the doctoral studies.
• Afterward, the first tranche of 90% of the funding will be disbursed.

3 months after project start (ONLY FOR FINAL FINANCING)

• Submission of a progress report, which must include:

1. Information on expenses incurred so far—extract from the accounting system.
2. Current project status (half a DIN A4 page is sufficient).

After project completion:

• Submission of a final report, which must include:

1. Comparison between the project proposal and project completion (description of the individual work packages, whether everything went according to plan, if objectives had to be adjusted, and key findings).
2. Which publications or similar outputs have resulted or are expected?
3. Information on follow-up funding and, for Start Funding, details on the continued employment of the student (the student must remain employed at PMU for 6 months after project completion as per the contract).
4. Financial summary: extract from the accounting system.
5. For Final Financing: if already available, the publication produced during the funding period.

• Afterwards, the second tranche of 10% of the funding will be disbursed.

6 weeks after completion of doctoral studies

• Submission of the doctoral thesis.

If desired, reports can be generated using our general template.

After funding approval

• Notification of the names and addresses of the workplace and supervisors for contract preparation.
• Provide a cost center (project-specific). If the project is being managed through PMU, you can apply for the cost center here; SALK employees should contact Ms. Zoll (i.zoll[at]salk.at).
• Provide the completion date of the external project application that forms the basis of the funding request.
• Afterward, the entire funding amount will be disbursed.

6 weeks after completion of the external project:

• Submission of a final report, which must include:

1. Report of the external application.
2. Financial summary: extract from the accounting system & invoices as PDFs.

• The final report will be reviewed and approved by a member of the RIF allocation board.

If desired, reports can be generated using our general template.

After funding approval

• Notification of the names and addresses of the workplace and supervisors for contract preparation.
• Provide personal bank details.
• Provide the start and end dates of the research stay.

• Afterwards, the entire funding amount will be disbursed.

   

6 weeks after completion of research stay

• Submission of a final report, which must include:

1. Confirmation from the host institution of the research stay (a brief two-line statement with the date, signed by the host institution, is sufficient).
2. Short report on the outcome of the research stay (How did the funding support the acquisition of scientific qualifications, skills, or assist in the completion of projects?).

If desired, reports can be generated using our general template.

Project: Identification of novel therapeutic targets in Pendred syndrome/DFNB4

Principal investigator (PI): Priv.-Doz. PhD Silvia Dossena

Institute(project lead): Institute of Pharmacology and Toxicology, PMU Salzburg

Collaborating organizational units/institutes: University Clinics of Otolaryngology, Head and Neck Surgery, Paracelsus
Medical University, Institute of Physiology and Pathophysiology – Salzburg

Project: Targeting Pericyte-like Cells for Functional Regeneration - Lessons learned from Tendon, Spinal Cord and Optic Nerve Injuries

Principal investigator (PI): Priv.-Doz. Dr. Herbert Tempfer

Institute: Institute of Tendon and Bone Regeneration

Collaborating organizational units/institutes: Institute for Molecular Regenerative Medicine, University Clinic of Ophthalmology and Optometry

Projekttitel: OBMAN-Management of Obesity in Salzburg

Principal investigator (PI): Mag. Dr. Dagmar Schaffler-Schaden

Institute: Institute of General Practice, Family Medicine and Preventive Medicine, PMU Salzburg

Collaborating organizational units/institutes: University Clinic of Geriatrics, University Clinic of Pediatrics, University Clinic of Internal Medicine I

Projekttitel: Establishment of biomarkers for migraine in the skin: A special focus on thermoreceptors

Principal investigator (PI): Prof. Priv.-Doz. Dr. Elisabeth Russe

Institute: Department of Plastic, Aesthetic and Reconstructive Surgery, Hospital of
St. John of God (Barmherzige Brüder) Salzburg

Collaborating organizational units/institutes: Department of Neurology, Christian Doppler University Hospital, Institute of Experimental and Clinical Cell Therapy, PMU Salzburg, Department of Pediatrics, PMU Salzburg, Department of Biosciences and Medical Biology, University of Salzburg

Projekttitel: Tackling fibrosis: A cross-organ, transcriptome-guided drug repurposing approach

Principal investigator (PI):  Priv.-Doz. Dr. Verena Wally

Institute: Department of Dermatology

Collaborating organizational units/institutes: Department of Ophthalmology, Department of Internal Medicine II - Division of Cardiology

Project: Fracture severity and post-traumatic inflammatory / chondrodegenerative biomarker levels in synovial fluid as risk factors for the development of post-traumatic osteoarthritis (PTOA) in tibial plafond fractures: a pilot study

Principal investigator (PI): Mag.a rer. nat. Katharina Trenkwalder

Institute(project lead): Institut for Biomechanics

Collaborating organizational units/institutes:  Department for Joint Surgery and Center for Arthroplasty / Institute for
Biomechanics

Project: 3D imaging of esophageal atresia in a rat model

Principal investigator (PI): Dr. rer. nat. Marco Ginzel

Institute(project lead): Department of Pediatric and Adolescent Surgery

Collaborating organizational units/institutes:  -

Project: Mapping the effector cell anatomy associated to intrathecal antibody production in neuroinfection – a pilot study targeting the role of B cells in CNS immune defense

Principal investigator (PI): Priv.-Doz. Dr. Mag. Andrea Harrer

Institute(project lead): Department of Neurology, Department of Dermatology and Allergology

Collaborating organizational units/institutes:  -
 

Project: A combinatorial approach for improved neuroprotection and regeneration in vitro

Principal investigator (PI): Dr. Bruno Benedetti

Institute(project lead): Institute of Experimental Neuroregeneration

Collaborating organizational units/institutes:  Inst. of Molecular Regenerative Medicine

Project: Ordered Membrane Domain Endocytosis (OMDE) in stem cell-derived neurons

Principal investigator (PI): Dr. Christine Deisl

Institute(project lead): Anatomy and Cell Biology

Collaborating organizational units/institutes: -

Project: Metabolic profiling of wound swabs in Epidermolysis Bullosa

Principal investigator (PI): Dr. Roland Zauner

Institute(project lead): Department of Dermatology and Allergology

Collaborating organizational units/institutes: Department of Pediatrics, Research Program for Receptor and Tumor
Metabolism, Laboratory for Diagnostics and Molecular Therapy
 

Project: Enhancing Biomedical Research with Multiple Contrast Tests: Development of an Open-Source Software and Application to Cerebrospinal Fluid Data in Neuroinflammation

Principal investigator (PI): Priv-Doz. Dr. Mag. Andrea Harrer

Institute(project lead): Department of Neurology

Collaborating organizational units/institutes: -

Project: Rewiring Recovery: contact-dependent and secretome-mediated crosstalk between tumor-associated macrophages and injured neurons

Principal investigator (PI): Dr. Bruno Benedetti

Institute(project lead): Institute of Experimental Neuroregeneration

Collaborating organizational units/institutes: -

Project: EV-olution: Advancing Mesenchymal Stem Cell Extracellular Vesicles to prevent epidural fibrosis after spinal surgery

Principal investigator (PI): Dr. Lara Bieler

Institute(project lead): Institute of Experimental Neuroregeneration

Collaborating organizational units/institutes: -

Project: Retinal blue light stimulation and choroidal downstream mechanisms

Principal investigator (PI): Christian Platzl

Institute(project lead): Institute of Anatomy and Cell Biology

Collaborating organizational units/institutes: -

Project: DNA-based methylation analysis to evaluate genetic and epigenetic alternations in aneurysmal subarachnoid hemorrhage and their effects on clinical course and long-term outcome

Principal investigator (PI): Dr. Arwin Rezai

Institute(project lead): Department for Neurosurgery

Collaborating organizational units/institutes: Institute for Pathology

Project: Measuring rapid structural brain plasticity using MRI: towards developing a biomarker

Principal investigator (PI): Dr. Lisa Kronbichler

Institute(project lead): Department of Psychiatry

Collaborating organizational units/institutes: -

Project: Development of dopamine receptor-associated pharmacological tools characterizing novel ligands for central nervous system diseases

Principal investigator (PI): Dr. Lukas Zell

Institute(project lead): Department of Psychiatry

Collaborating organizational units/institutes: -

Project: Dissecting How Ketogenic Diet and Immunotherapy Reprogram Neuroblastoma and Its Microenvironment

Principal investigator (PI): Victoria Stefan MSc

Institute(project lead): Department of Pediatrics

Collaborating organizational units/institutes: -

Project: Cysteinyl leukotriene receptor 1 and its role in regulating proteasome activity of retinal pigment epithelial cells

Principal investigator (PI): Victoria Stefan MSc

Institute(project lead): Department of Pediatrics

Collaborating organizational units/institutes: -

Project: Cysteinyl leukotriene receptor 1 and its role in regulating proteasome activity of retinal pigment epithelial cells

Principal investigator (PI): Priv.-Doz. Dr. Andreas Koller MSc

Institute(project lead): Research Program of Experimental Ophthalmology and Glaucoma Research
 

Collaborating organizational units/institutes: -

Currently no projects.

Project: Characterization of imaging abnormalities and determining their prognostic value in patients with status epilepticus

Principal investigator (PI): Priv.-Doz. Dr. Giorgi Kuchukhidze

Institute(project lead): Department of Neurology

Collaborating organizational units/institutes: -

Project: Epigenetic modifiers of disease phenotypes: epidermolysis bullosa as a paradigm

Principal investigator (PI): Priv.-Doz. Dr. Verena Wally

Institute(project lead): Department of Dermatology and Allergology

Collaborating organizational units/institutes: -

Project: SPARCling matrix – the essential role of ihe matricellular protein SPARC in tendon disease &
healing

Principal investigator (PI): Prof. Dr. Andreas Traweger

Institute(project lead): Institute of Tendon and Bone Regeneration

Collaborating organizational units/institutes: -

Project: HEAL

Principal investigator (PI): Univ.Prof. Dr. Dirk Strunk

Institute(project lead): Institute for Experimental and Clinical Cell Therapy

Collaborating organizational units/institutes: -

Project: Transcriptome-guided drug repurposing for the treatment of aggressive SCCs

Principal investigator (PI): Dr. Sonja Dorfer

Institute(project lead): Department of Dermatology and Allergology

Collaborating organizational units/institutes: -

Project: Myopia - from genes and environment to cellular responses and treatment MYOTREAT European Commission Horizon-TMA-MSCA-DN, 101119501

Principal investigator (PI): Prof.Dr. Falk Schrödl

Institute(project lead): Institute of Anatomy and Cell Biology

Collaborating organizational units/institutes: -

Project: Investigating the Potential of Repurposing Statins for the Treatment of highly aggressive RDEB-Tumour.

Principal investigator (PI): Dr. Roland Zauner

Institute(project lead): Department of Dermatology and Allergology

Collaborating organizational units/institutes: -

Project: GENOMIT: A Multi-Omics Approach for Mitochondrial defects

Principal investigator (PI): Priv.-Doz Dr. Johannes A. Mayr

Institute(project lead): University Children's Hospital

Collaborating organizational units/institutes: -

Project: Role of Renal Intercalated Cells in Alkali Sensing (sense-pH)

Principal investigator (PI): Priv.-Doz Dr. Silvia Dossena

Institute(project lead): Institute of Pharmacology and Toxicology

Collaborating organizational units/institutes: -

Project: Prevention of Adverse Effects in Pediatric Drug Therapy - Offlabel Use

Principal investigator (PI): De DeHabib Bader

Institute(project lead): Institute of Pharmacy

Collaborating organizational units/institutes: -

Project: Characterization of imaging abnormalities and determining their prognostic value in patients with status epilepticus

Principal investigator (PI): Priv.-Doz. Dr. Giorgi Kuchukhidze

Institute(project lead): Department of Neurology

Collaborating organizational units/institutes: -